Official AMFI data
Arthkar — Understand Money, Invest Smartly
quant

Quant Multi Cap Fund

Multi CapEquityVery High risk Rank 22 of 24

NAV · Direct-Growth

₹732.45-5.29-0.72%

As of 31 Aug 2026 · AMFI

NAV growth+11.3%
Sep ’25Aug ’26
Arthkar verdictMixed picture

Returns

Mixed vs category

1 of 3 periods ahead

Cost

High

1.01% vs 0.71% peers

Volatility

Above average

18.1% vs 16.2% cat (3Y)

Consistency

Steady

positive in 9 of 12 years

Beats its Multi Cap category on 1Y but trails on 3Y & 5Y — but has run more volatile than peers.

1Y return

+12.7%

+3.4 vs cat

3Y CAGR

+11.1%

-2.7 vs cat

5Y CAGR

+12.8%

-0.8 vs cat

AUM

₹7.7K Cr

fund size

Expense

1.01%

direct plan

Volatility 3Y

18.1%

▲ vs 16.2%

Go deeper on Quant Multi Cap Fund

Two data-only views, computed from this fund's real NAV history — no projections.

In plain English

quant Multi Cap Fund is a Multi Cap scheme from quant. The portfolio is ~99% in equities. Within equity, ~38% sits in large-cap stocks, 22% in mid-cap, and 26% in small-cap. Long-run track record: about 12.8% CAGR over 5 years. Volatility is high — expect 30 %+ paper losses during major corrections. Worst historical drawdown: -36% in Mar 2020, recovered in 4 months. Wrong fit if you need this money in less than 5 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF966L01614

NAV (Direct-Growth)

₹732.4530

Last 1Y

+11.32%

Sept 25Min ₹589.05 · Max ₹737.74 · 247 ptsAug 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Mar 2020

-36.3%

Peak ₹197.63 on 31 Oct 2019 → trough ₹125.97 on 23 Mar 2020 (5 months down).

Recovered in 4 months· 23 Jul 2020

Mar 2025 — ongoing

-25.3%

Peak ₹788.23 on 31 Jul 2024 → trough ₹588.79 on 3 Mar 2025 (7 months down).

Not yet recovered

Aug 2013

-23.0%

Peak ₹73.90 on 8 Jan 2013 → trough ₹56.93 on 28 Aug 2013 (8 months down).

Recovered in 6 months· 7 Mar 2014

Jun 2022

-20.7%

Peak ₹470.14 on 11 Apr 2022 → trough ₹372.96 on 20 Jun 2022 (2 months down).

Recovered in 3 months· 8 Sept 2022

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    1.01% — above the typical 1% for equity.

  • AUM size

    ₹7.7K Cr.

  • Sector concentration

    Top 3 sectors = 33.9% — diversified across sectors.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+0.53%+0.51%19/ 37
1M+1.03%+2.94%31/ 37
3M+3.67%+5.87%34/ 37
6M+17.05%+9.56%5/ 37
YTD+9.84%+5.09%12/ 37
1Y+12.73%+9.33%19/ 37
2Y-2.85%+2.27%29/ 31
3Y+11.14%+13.87%22/ 24
5Y+12.82%+13.66%9/ 11
7Y+22.92%+18.25%2/ 10
10Y+18.04%+13.08%1/ 8

Portfolio composition

Asset allocation

  • Equity98.98%
  • Cash1.01%
  • Other0.01%

By market cap

  • Large cap37.86%
  • Mid cap21.85%
  • Small cap26.34%
  • Others13.95%

Concentration

Holdings

77

Avg market cap

₹82.4K Cr

Top 10 stocks

42.06%

Top 5 stocks

27.94%

Top 3 sectors

33.89%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 3

    Aurobindo Pharma Ltd

    8.72%
  • 3

    Aurobindo Pharma Ltd

    8.72%
  • 3

    Adani Power Ltd

    8.63%
  • 3

    Adani Power Ltd

    8.63%
  • 3

    Adani Power Ltd

    8.63%
  • 3

    Adani Power Ltd

    8.63%
  • 3

    Adani Power Ltd

    8.63%
  • 3

    Aurobindo Pharma Ltd

    8.52%
  • 4

    Aurobindo Pharma Ltd

    7.99%
  • 4

    Aurobindo Pharma Ltd

    7.99%
  • 4

    Aurobindo Pharma Ltd

    7.99%
  • 4

    Aurobindo Pharma Ltd

    7.99%
  • 4

    Aurobindo Pharma Ltd

    7.99%
  • 5

    Midcapnifty 26/05/2026

    7.64%
  • 5

    Midcapnifty 26/05/2026

    7.64%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio24.1827.81-3.63
  • P/B ratio2.593.93-1.34
  • Price / Sales2.453.32-0.87
  • Price / Cash Flow16.9621.20-4.24
  • Dividend yield1.11%0.96%+0.15
  • Return on equity (ROE)13.26%17.22%-3.96

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    17.5318.1217.3218.2016.2315.45
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.180.330.440.080.570.57
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    0.340.530.710.140.870.88
  • Beta

    1 = moves with the market. <1 = less volatile.

    1.011.041.040.960.960.96

Peers in Multi Cap

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.